论文部分内容阅读
糖尿病心肌病(diabetic cardiomyopathy,DCM)是发生于糖尿病患者的一种特异性心肌疾病,其临床表现主要包括充血性心力衰竭、心绞痛等[1]。糖尿病心肌病患者临床检查多显示血糖和糖化血红蛋白增高、左室舒张功能的异常、窦性心动过速、24小时内心率变异性减弱或消失等现象,对社会和家庭都带来了严重的负担。GLP-1及其类似物具有十分重要的心血管保护作用,能显著增加心肌对葡萄糖
Diabetic cardiomyopathy (DCM) is a specific type of myocardial disease that occurs in diabetic patients. Its clinical manifestations include congestive heart failure and angina pectoris [1]. Clinical manifestations of patients with diabetic cardiomyopathy more blood glucose and glycosylated hemoglobin, abnormal diastolic left ventricular function, sinus tachycardia, heart rate variability within 24 hours weakened or disappeared, etc., have a serious burden on society and families . GLP-1 and its analogs have a very important cardiovascular protective effect, can significantly increase the myocardial glucose